Camille L. Bedrosian MD

Camille is the Senior Vice President and Chief Medical Officer at Alexion Pharmaceuticals. A medical oncologist and haematologist, she brings more than 25 years of academic medical practice, research and drug development expertise to this role. At Alexion, she has provided leadership for the development of drugs and drug candidates across therapeutic areas encompassing complement-mediated diseases, including for Alexion’s marketed terminal complement inhibitor eculizumab, as well as more recently, therapeutics in the metabolic disease area.